-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CampETEC in Campylobacter Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CampETEC in Campylobacter Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CampETEC in Campylobacter Infections Drug Details: Antibody is under development for the...
-
Product Insights
NewInfectious Diarrhea – Drugs In Development, 2024
Empower your strategies with our Infectious Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Infectious Diarrhea is a common gastrointestinal infection and the most common type of diarrhea. Diarrhea is defined as frequent bowel movements that are loose, watery, and associated with nausea, vomiting, and fatigue. Bacterial, viral, and protozoans are the common pathogens leading to infectious diarrhea. E. coli-associated infections are the most common bacteria while Entamoeba histolytica is a common parasite causing infectious diarrhea....
-
Product Insights
NewTraveler’s Diarrhea – Drugs In Development, 2024
Empower your strategies with our Traveler's Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Traveler's diarrhea occurs within 10 days of travel to an area with poor public hygiene. The most common illness in travelers, it is caused by drinking water or eating food that contains bacteria, viruses, or parasites. Most traveler's diarrhea is from bacteria. It often goes away in a few days. Often, the only treatment is fluid replacement. The Traveler's Diarrhea drugs in...
-
Product Insights
NewBacillary Dysentery (Shigellosis) – Drugs In Development, 2024
Empower your strategies with our Bacillary Dysentery (Shigellosis) – Drugs In Development, 2024 report and make more profitable business decisions. Shigella infection (shigellosis) is an intestinal disease caused by bacteria known as shigella. Symptoms include diarrhea, abdominal cramps, and fever. Predisposing factors include eating contaminated food, age, international travel, and being a homosexual man. Treatment includes antibiotics. The Bacillary Dysentery (Shigellosis) drugs in development market research report provide comprehensive information on the therapeutics under development for Bacillary Dysentery (Shigellosis), complete with...
-
Product Insights
NewDiarrhea – Drugs In Development, 2024
Empower your strategies with our Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. The Diarrhea drugs in development market research report...
-
Product Insights
NewColitis – Drugs In Development, 2024
Empower your strategies with our Colitis – Drugs In Development, 2024 report and make more profitable business decisions. Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections with a virus or parasite or bacterial food poisoning; inflammatory disorders, namelsy ulcerative colitis and Crohn's disease; lack of blood flow (ischemic colitis); or past radiation exposure to the large bowel. Symptoms can include abdominal pain, bloating, bloody stools, chills, dehydration, diarrhea, and fever. Treatment includes...
-
Product Insights
NewEscherichia coli Infections – Drugs In Development, 2024
Empower your strategies with our Escherichia coli Infections – Drugs In Development, 2024 report and make more profitable business decisions. Escherichia coli (E. coli) bacteria normally live in the intestines of healthy people and animals. E. coli infections are caused by coming into contact with the feces of humans or animals, or eating or drinking contaminated food or beverage. Symptoms include diarrhea, which may range from mild and watery to severe and bloody; abdominal cramping; pain or tenderness; nausea; and vomiting....
-
Product Insights
NewClostridioides difficile Infections (Clostridium difficile Associated Disease) – Drugs In Development, 2024
Empower your strategies with our Clostridioides difficile Infections (Clostridium difficile Associated Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Clostridium difficile infections are caused by Clostridium difficile, often called C. difficile or "C. diff", a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. Symptoms of C. diff infection include watery diarrhea with abdominal pain or tenderness, loss of appetite, fever, blood or pus in the stool, and weight loss. Risk...
-
Product Insights
NewUrinary Tract Infections – Drugs In Development, 2024
Empower your strategies with our Urinary Tract Infections – Drugs In Development, 2024 report and make more profitable business decisions. A urinary tract infection (UTI) is a bacterial infection that can occur in any part of the urinary system, including the kidneys, bladder, ureters, and urethra. Common symptoms include pain or burning during urination, frequent urination, urgency, lower abdominal discomfort, and cloudy or foul-smelling urine. UTIs are more common in women, and risk factors include factors such as sexual activity, urinary...
-
Product Insights
NewAutism Spectrum Disorder (ASD) – Drugs In Development, 2024
Empower your strategies with our Autism Spectrum Disorder (ASD) – Drugs In Development, 2024 report and make more profitable business decisions. Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social interaction, communication, and repetitive behaviors. Symptoms range from mild to severe, forming a spectrum. Individuals with ASD may have difficulties in understanding social cues, expressing emotions, and engaging in reciprocal conversations. Sensory sensitivities are common, affecting responses to stimuli. Early intervention and tailored support can enhance communication...